8-K: Cardlytics Completes Bridg Platform Sale to PAR Technology

Cardlytics, Inc. has completed the sale of its Bridg platform to PAR Technology Corporation, receiving 1,810,222 shares of PAR common stock as consideration.

Summary

• Cardlytics, Inc. completed the sale of its Bridg platform to PAR Technology Corporation and its indirectly wholly owned subsidiary, DB Sub, LLC, on March 24, 2026.
• The consideration for the Bridg Sale was 1,810,222 shares of PAR Technology Corporation's common stock.
• The transaction was previously disclosed in a Current Report on Form 8-K filed on January 26, 2026, following an asset purchase agreement dated January 23, 2026.
• The company expects an estimated gain of $13.9 million related to the transaction.
• Approximately $1.6 million in transaction costs are expected to be incurred subsequent to December 31, 2025.
• Unaudited pro forma financial statements reclassify the Bridg business as discontinued operations for all periods presented (years ended December 31, 2025, 2024, and 2023).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it represents the successful execution of a previously announced strategic divestiture, which is expected to streamline operations and result in a gain.

Positives

• Successful completion of the Bridg platform divestiture, streamlining operations and allowing for a clearer focus on the core continuing business.
• Receipt of 1,810,222 shares of PAR Technology common stock as consideration, providing a liquid asset or potential future equity upside in PAR.
• An estimated gain on divestiture of $13.9 million is expected, which could enhance shareholder value.

Negatives

• The company expects to incur approximately $1.6 million in transaction costs subsequent to December 31, 2025.
• The actual gain recorded upon close may be subject to change based on amounts as of the close date.
• The pro forma financial statements do not reflect all actions that may be undertaken by the company following the closing of the transaction, nor do they reflect the realization of any expected cost savings, synergies, or dis-synergies.

Risks

• The unaudited pro forma condensed consolidated financial statements are for illustrative and informational purposes only and are not necessarily indicative of the company's financial position and results of operations for any future period.
• The actual financial position and results of operations may differ significantly from the pro forma amounts reflected due to a variety of factors.
• The preliminary estimates for discontinued operations accounting could change as the company finalizes reporting for future quarterly and annual reports.

Future Outlook

The filing primarily reports a completed transaction and provides pro forma financial statements. It notes that these pro forma statements are for illustrative purposes only, are not necessarily indicative of future financial position or results, and do not reflect all potential post-transaction actions or any expected cost savings, synergies, or dis-synergies.

Industry Context

StockSavvy.ai notes that the divestiture of the Bridg platform suggests Cardlytics is refining its strategic focus, potentially shedding non-core assets to concentrate on its primary card-linked offer business. This move could be interpreted as a strategic realignment to improve profitability and operational efficiency in a competitive ad-tech and financial services landscape. The receipt of PAR Technology stock indicates a potential strategic partnership or a belief in PAR's future value.

Stakeholder Impact

• Shareholders: Expected to benefit from the estimated gain on divestiture and a more focused core business. Holders of PAR Technology stock will see an increase in outstanding shares.
• Employees: Bridg employees are likely transferred to PAR Technology or impacted by the sale.
• Customers: Bridg customers will now be served by PAR Technology.

Next Steps

• Finalization of discontinued operations accounting to be reported in Quarterly Reports on Form 10-Q for the three months ending March 31, 2026, six months ending June 30, 2026, nine months ending September 30, 2026, and Annual Report on Form 10-K for the year ending December 31, 2026.

Key Dates

Recommendation

The completion of the divestiture is a positive step towards streamlining operations and realizing a gain. However, the pro forma financials still show significant net losses for the continuing operations, and the long-term impact of shedding Bridg on overall growth and profitability needs further observation. The receipt of PAR stock introduces a new variable, and investors should monitor how Cardlytics leverages this strategic realignment.

Keywords

Cardlytics, CDLX, PAR Technology, PAR, Bridg, divestiture, asset sale, discontinued operations, pro forma financials, SEC filing, 8-K, financial technology, ad-tech